Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, diagnosis to cure. With specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics, Revvity positions itself as a solutions company that leverages innovation across life sciences and diagnostics and more. The Waltham, Massachusetts–based company is a true multinational with over 10,000 employees worldwide.